Agenda
Two meeting options, 2nd October, 9 am CEST, and 5 pm CEST
Welcome
09:00 - 09:15
News From the Trial
09:15 - 10:45
The landscape of approved AD medication and evoke/evoke+
10:45 - 11:00
Support for patients and study partners at risk of withdrawal
11:00 - 11:45
Closure
11:45 - 12:30
Speakers
To Be Announced
TBC
TBC
TBC
TBC
TBC
TBC
TBC
TBC
TBC
TBC
